Your browser doesn't support javascript.
loading
An Evidence-Based Nursing Intervention Decreases Anxiety, Depression, Sleep Quality and Somatic Symptoms of Patients with Acute Ischemic Stroke.
Gao, Wen-Juan; Bao, Wen-Juan; Sun, Su-Juan.
Afiliação
  • Gao WJ; Neurology, Hebei General Hospital, Shijiazhuang City, Hebei 050051, People's Republic of China.
  • Bao WJ; Department of Hepato-Biliary-Pancreatic Surgery, Hebei General Hospital, Shijiazhuang City, Hebei, 050051, People's Republic of China.
  • Sun SJ; Nursing Department, Hebei General Hospital, Shijiazhuang City, Hebei, 050051, People's Republic of China.
Neuropsychiatr Dis Treat ; 18: 2443-2451, 2022.
Article em En | MEDLINE | ID: mdl-36317117
ABSTRACT

Purpose:

This study aimed to explore the effects of evidence-based nursing (EBN) intervention on anxiety, depression, sleep quality and somatic symptoms of patients with acute ischemic stroke (AIS).

Methods:

The eligible AIS patients were randomized into the intervention group and control group in a 11 ratio. Patients in both groups received routine nursing care. On the basis of routine nursing, patients in the intervention group also received EBN. Self-rating anxiety scale (SAS), self-rating depression scale (SDS), Pittsburgh Sleep Quality Index (PSQI), and the Patient Health Questionnaire-15 (PHQ-15) were used to assess patients' anxiety, depression, sleep quality, and somatic symptoms at baseline (T0) and 6 months after intervention (T1), respectively.

Results:

There was no difference in SAS, SDS, PSQI, and PHQ-15 scores at T0 between the 2 groups (all P > 0.05). Comparing to the control group, the intervention group had significantly lower SAS and SDS scores at T1 (P = 0.002, P < 0.001, respectively). The SAS and SDS score changes (T1-T0) were more evident in the intervention group than in the control group (all P < 0.001). No difference of PSQI or PHQ-15 score between the 2 groups was observed at T1. However, the PSQI and PHQ-15 score changes were more evident in the intervention group than in the control group (P = 0.044 and P = 0.007, respectively).

Conclusion:

EBN invention significantly improved anxiety, depression, sleep quality and somatic symptoms of patients with AIS.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article